search
Back to results

Post-Procedural Biotech Cellulose Mask

Primary Purpose

Temperature Change, Body

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Velez Intense Hydration Mask® (biotech cellulose face mask)
Sponsored by
Siperstein Dermatology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Temperature Change, Body

Eligibility Criteria

22 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Patients willing to undergo a cosmetic procedure Patients willing to apply a mask for 30 minutes after the procedure and daily Patients willing to return to the office to take photos daily and allow use of photos in publication Exclusion Criteria: History of auto-immune conditions History of keloids History of severe anaphylactic reactions Patients taking either anti-coagulants, chemotherapy, immunosuppressive agents, immunomodulatory agents, diuretics, antihistamines, or anti-inflammatory two weeks before or during planned treatments Patients who are pregnant or nursing.

Sites / Locations

  • Siperstein Dermatology Group

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Velez Intense Hydration Mask® (biotech cellulose face mask) Right Side

Velez Intense Hydration Mask® (biotech cellulose face mask) Left Side

Arm Description

For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the right side of the face

For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the left side of the face

Outcomes

Primary Outcome Measures

Temperature
Change in skin temperature

Secondary Outcome Measures

Full Information

First Posted
September 20, 2023
Last Updated
September 26, 2023
Sponsor
Siperstein Dermatology
search

1. Study Identification

Unique Protocol Identification Number
NCT06065332
Brief Title
Post-Procedural Biotech Cellulose Mask
Official Title
Randomized Split-Face Study Using a Post-Procedural Biotech Cellulose Mask to Improve Patient Comfort & Downtime
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
November 7, 2022 (Actual)
Primary Completion Date
December 9, 2022 (Actual)
Study Completion Date
March 2, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Siperstein Dermatology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: There are many post-procedural treatments touted to improve comfort and decrease downtime, but very few prospective randomized studies. Aims: To analyze the safety and efficacy of a post-procedural biotech cellulose mask Patients/Method: Fifteen patients undergoing either a microneedling with radiofrequency (n=5), non-ablative fractional (n=5), or full erbium;YAG resurfacing (n=5) treatment were randomized to receive a Velez biotech cellulose mask on one side of the face for 30 minutes after the procedure and for two hours a day until healed. Canfield Visia photos and thermal photographs were taken 30 minutes after the procedure and daily until healed. The investigator and blind evaluators reviewed the photos and subjects answered daily questionnaires.
Detailed Description
A dual center study was performed at a private practice in Boynton Beach and Boca Raton Florida. The study was carried out in accordance with the ethical guidelines and principles of the 1975 Declaration of Helsinki and good clinical practice. The protocol was approved on May 12th, 2022, by Sterling IRB. Study Design: The clinical research coordinator and investigator recruited, enrolled, and assigned 15 subjects into 3 arms, each with 5 subjects over two months. The side assigned a biotech cellulose mask for each subject was determined by random sorting using a computer-generated sequence and written on a label adhered to the mask packaging so the patient could remember while at home. Treatment: Topical anesthetic cream (benzocaine 20%, lidocaine 10%, and tetracaine 6%) was applied to the face for 30 minutes and wiped off with 70% isopropyl alcohol in all three arms. Those in arm 1 received a non-ablative fractionated thulium treatment (Moxi; Sciton) those in arm 2 received a microneedling with radiofrequency treatment (Secret; Cutera), and those in arm 3 received a fully ablative erbium yttrium aluminum garnet (Er:YAG) laser resurfacing (Contour TRL; Sciton). Immediately after the procedure a biotech cellulose mask was applied (Hydration mask; Velez by Vesna) and left on for thirty minutes. Then digital photography using Canfield's imaging system and Flir's thermal camera was done. In addition, a subject questionnaire on satisfaction, erythema, edema, and pain levels after the procedure was completed. Patients used the typical post-care treatment on both sides of their face such as Vaseline for laser resurfacing and a hydrating serum for the NAFR and MRF. They were given additional half-sided masks to apply to the same assigned side of their face at home for at least two hours each day for the duration of the study. They returned to the office daily for questionnaires and photographs until deemed fully healed by the primary investigator signifying the end of the study. At all follow up visits, the primary investigator assessed the subject for any side effects and subjects were asked about side effects in questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Temperature Change, Body

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
The blind evaluator were not aware which side of the face received the mask
Allocation
Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Velez Intense Hydration Mask® (biotech cellulose face mask) Right Side
Arm Type
Experimental
Arm Description
For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the right side of the face
Arm Title
Velez Intense Hydration Mask® (biotech cellulose face mask) Left Side
Arm Type
Experimental
Arm Description
For 30 minutes after an aesthetic procedure, a Velez Intense Hydration Mask® (biotech cellulose face mask) was applied to the left side of the face
Intervention Type
Other
Intervention Name(s)
Velez Intense Hydration Mask® (biotech cellulose face mask)
Intervention Description
Application to one randomized side half of a Velez Intense Hydration Mask® (biotech cellulose face mask)
Primary Outcome Measure Information:
Title
Temperature
Description
Change in skin temperature
Time Frame
30 minutes after the procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients willing to undergo a cosmetic procedure Patients willing to apply a mask for 30 minutes after the procedure and daily Patients willing to return to the office to take photos daily and allow use of photos in publication Exclusion Criteria: History of auto-immune conditions History of keloids History of severe anaphylactic reactions Patients taking either anti-coagulants, chemotherapy, immunosuppressive agents, immunomodulatory agents, diuretics, antihistamines, or anti-inflammatory two weeks before or during planned treatments Patients who are pregnant or nursing.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robyn D Siperstein, MD
Organizational Affiliation
Siperstein Dermatology Group
Official's Role
Principal Investigator
Facility Information:
Facility Name
Siperstein Dermatology Group
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33472
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Post-Procedural Biotech Cellulose Mask

We'll reach out to this number within 24 hrs